Abstract
After successful treatment of early breast cancer, many women still report pain symptoms, and attribute them to the previous illness or its treatment. However, knowledge about the long-term course of pain in breast cancer is limited. Baseline assessment included 3,088 women who received a breast cancer diagnosis on average 2 years prior to enrollment, and who completed typical medical treatments. After 4 years, a subsample of 2,160 recurrence-free women (70%) was re-assessed. The major outcome variable was the composite index for general pain symptoms. Over the 4-year course, a slight but significant increase in pain was reported. If only medical variables were examined, a triple interaction between surgery type, breast cancer stage, and time indicated that pain scores increased in most subgroups, while they decreased in stage II women after mastectomy and stage III women after lumpectomy. Using a regression analytical approach, psychological and other variables added significantly to the prediction of pain persistence. Regression analysis revealed that pain symptoms increased in those women taking tamoxifen at baseline, in those reporting depression at baseline or stressful life events during the first 12 months after enrollment. Exercise at baseline had a beneficial effect on pain recovery. The persistence or increase of pain symptoms in women surviving breast cancer is associated with some medical factors (surgery type, tamoxifen use), but also with psychological factors. Pain should be a standard outcome variable in the evaluation of cancer treatment programs.
Similar content being viewed by others
References
Burkey AR, Kanetsky PA (2009) Development of a novel location-based assessment of sensory symptoms in cancer patients: preliminary reliability and validity assessment. J Pain Symptom Manage 37:848–862
Gartner R, Jensen M-B, Nielsen J, Ewertz M, Kroman N, Kehlet H (2009) Prevalence of and factors associated with persistent pain following breast cancer surgery. JAMA 302:1985–1992
Geels P, Eisenhauer E, Bezjak A, Zee B, Day A (2000) Palliative effect of chemotherapy: objective tumor response is associated with symptom improvement in patients with metastatic breast cancer. J Clin Oncol 18:2395–2405
Bower JE (2005) Prevalence and causes of fatigue after cancer treatment: the next generation of research. J Clin Oncol 23:8280–8282
Reyes-Gibby CC, Aday LA, Anderson KO, Mendoza TR, Cleeland CS (2006) Pain, depression, and fatigue in community-dwelling adults with and without a history of cancer. J Pain Symptom Manage 32:118–128
Rummans TA, Frost M, Suman VJ, Taylor M, Novotny P, Gendron T, Johnson R, Hartmann L, Dose AM, Evans RW (1998) Quality of life and pain in patients with recurrent breast and gynecologic cancer. Psychosomatics 39:437–445
Kroenke K, Zhong X, Theobald D, Wu J, Tu W, Carpenter JS (2010) Somatic symptoms in patients with cancer experiencing pain or depression: prevalence, disability, and health care use. Arch Intern Med 170:1686–1694
Gotay CC, Kawamoto CT, Bottomley A, Efficace F (2008) The prognostic significance of patient-reported outcomes in cancer clinical trials. J Clin Oncol 26:1355–1363
Quinten C, Coens C, Mauer M, Comte S, Sprangers MAG, Cleeland C, Osoba D, Bjordal K, Bottomley A (2009) Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials. Lancet Oncol 10:865–871
Montazeri A (2009) Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008. Health Qual Life Outcomes 7:102. doi:110.1186/1477-7525-1187-1102
Heutte N, Flechtner HH, Mounier N, Mellink WAM, Meerwaldt JH, Eghbali H, van’t Veer MB, Noordijk EM, Kluin-Nelemans JC, Lampka E, Thomas J, Lugtenburg PJ, Viterbo L, Carde P, Hagenbeek A, van der Maazen RWM, Smit WGJM, Brice P, van Marwijk Kooy M, Baars JW, Poortmans P, Tirelli U, Leeksma OC, Tomsic R, Feugier P, Salles G, Gabarre J, Kersten MJ, Van Den Neste E, Creemers G-JM, Gaillard I, Meijnders P, Tertian G, Reman O, Muller HP, Troncy J, Blanc M, Schroyens W, Voogt PJ, Wijermans P, Rieux C, Fermé C, Henry-Amar M (2009) Quality of life after successful treatment of early-stage Hodgkin’s lymphoma: 10-year follow-up of the EORTC-GELA H8 randomised controlled trial. Lancet Oncol 10:1160–1170
Stone LS (2009) Joint degeneration and chronic pain: still looking for the missing link. Pain 141:185–186
Jung BF, Ahrendt GM, Oaklander AL, Dworkin RH (2003) Neuropathic pain following breast cancer surgery: proposed classification and research update. Pain 104:1–13
Henry NL, Jacobson JA, Banerjee M, Hayden J, Smerage JB, Van Poznak C, Storniolo AM, Stearns V, Hayes DF (2010) A prospective study of aromatase inhibitor-associated musculoskeletal symptoms and abnormalities on serial high-resolution wrist ultrasonography. Cancer 116:4360–4367
Hwang SS, Chang VT, Kasimis B (2003) Cancer breakthrough pain characteristics and responses to treatment at a VA medical center. Pain 101:55–64
International Association for the Study of Pain (IASP) (2010) IASP pain terminology. http://www.iasp-pain.org/AM/Template.cfm?Section=Pain_Definitions&Template=/CM/HTMLDisplay.cfm&ContentID=1728#Pain
Koyama T, McHaffie JG, Laurienti PJ, Coghill RC (2005) The subjective experience of pain: where expectations become reality. Proc Natl Acad Sci 102:12950–12955
Hiller W, Rief W, Brähler E (2006) Somatization in the population: from mild bodily misperceptions to disabling symptoms. Soc Psychiatry Psychiatr Epidemiol 41:704–712
Rief W, Hessel A, Braehler E (2001) Somatization symptoms and hypochondriacal features in the general population. Psychosom Med 63:595–602
Jensen MP (2003) The validity and reliability of pain measures in adults with cancer. J Pain 4:2–21
Pierce JP, Natarajan L, Caan BJ, Parker BA, Greenberg ER, Flatt SW, Rock CL, Kealey S, Al-Delaimy WK, Bardwell WA, Carlson RW, Emond JA, Faerber S, Gold EB, Hajek RA, Hollenbach K, Jones LA, Karanja N, Madlensky L, Marshall J, Newman VA, Ritenbaugh C, Thomson CA, Wasserman L, Stefanick ML (2007) Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: the Women’s Healthy Eating and Living (WHEL) randomized trial. JAMA 298:289–298
Bardwell WA, Profant J, Casden DR, Dimsdale JE, Ancoli-Israel S, Natarajan L, Rock CL, Pierce JP, for the Women’s Healthy E, Living Study G (2008) The relative importance of specific risk factors for insomnia in women treated for early-stage breast cancer. Psycho-Oncology 17:9–18
Matthews KA, Wing RR, Kuller LH, Meilahn EN, Plantinga P (1994) Influence of the perimenopause on cardiovascular risk factors and symptoms of middle-aged healthy women. Arch Intern Med 154:2349
McHorney CA, War JE Jr, Lu JFR, Sherbourne CD (1994) The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Medical Care 32:40–66
Radloff LS (1977) The CES-D Scale: a self-report depression scale for research in the general population. J Appl Psychol Meas 1:385–401
Carver CS, Smith RG, Antoni MH, Petronis VM, Weiss S, Derhagopian RP (2005) Optimistic personality and psychosocial well-being during treatment predict psychosocial well-being among long-term survivors of breast cancer. Health Psychol 24:508–516
Scheier MF, Carver CS, Bridges MW (1994) Distinguishing optimism from neuroticism (and trait anxiety, self-mastery, and self-esteem): a reevaluation of the Life Orientation Test. J Pers Soc Psychol 67:1063
Maunsell E, Brisson J, Deschenes L (1995) Social support and survival among women with breast cancer. Cancer 76:631
Sherbourne CD, Stewart AL (1991) The MOS social support survey. Soc Sci Med 32:705–714
Cadmus Bertram LA, Stefanick ML, Saquib N, Natarajan L, Patterson RE, Bardwell WA, Flatt SW, Newman VA, Rock C, Thomson CA, Pierce JP (2011) Physical activity, additional breast cancer events, and mortality among early stage breast cancer survivors: findings from the WHEL study. Cancer Causes Control 22:427–435
Berkman LF, Syme SL (1979) Social networks, host resistance, and mortality: a nine-year follow-up study of Alameda County residents. Am J Epidemiol 109:186–204
Booth CM, Li G, Zhang-Salomons J, Mackillop WJ (2010) The impact of socioeconomic status on stage of cancer at diagnosis and survival. Cancer 116:4160–4167
Rief W, Hennings A, Riemer S, Euteneuer F (2010) Psychobiological differences between depression and somatization. J Psychosom Res 68:495–502
Aukst-Margeti B, Jakovljevi M, Margeti B, Bišan M, Šamija M (2005) Religiosity, depression and pain in patients with breast cancer. Gen Hosp Psychiatry 27:250–255
Pinquart M, Duberstein PR (2010) Depression and cancer mortality: a meta-analysis. Psychol Med 40:1797–1810
Drachmann Bukh J, Bock C, Vinberg M, Werge T, Gether U, Vedel Kessing L (2009) Interaction between genetic polymorphisms and stressful life events in first episode depression. J Affect Disord 119:107–115
Skillgate E, Vingard E, Josephson M, Theorell T, Alfredsson L (2007) Life events and the risk of low back and neck/shoulder pain of the kind people are seeking care for: results from the MUSIC-Norrtälje case control study. J Epidemiol Community Health 61:356–361
Oxana Gronskaya P, Tani S, Jeanne L, Sidney E, Xin-Hua C, Cheryl K, Julie MT-C, Mary Anne K, Kathy G, Rebecca P (2006) Emotional self-efficacy, stressful life events, and satisfaction with social support in relation to mood disturbance among women living with breast cancer in rural communities. Breast J 12:123–129
McNeely ML, Campbell KL, Rowe BH, Klassen TP, Mackey JR, Courneya KS (2006) Effects of exercise on breast cancer patients and survivors: a systematic review and meta-analysis. CMAJ 175:34–41
Mutrie N, Campbell AM, Whyte F, McConnachie A, Emslie C, Lee L, Kearney N, Walker A, Ritchie D (2007) Benefits of supervised group exercise programme for women being treated for early stage breast cancer: pragmatic randomised controlled trial. BMJ 334:517
Knols R, Aaronson NK, Uebelhart D, Fransen J, Aufdemkampe G (2005) Physical exercise in cancer patients during and after medical treatment: a systematic review of randomized and controlled clinical trials. J Clin Oncol 23:3830–3842
Giovannucci EL, Liu Y, Leitzmann MF, Stampfer MJ, Willett WC (2006) A prospective study of physical activity and incident and fatal prostate cancer. J Urol 175:151–152
Smith GD, Shipley MJ, Batty GD, Morris JN, Marmot M (2000) Physical activity and cause-specific mortality in the Whitehall study. Public Health 114:308–315
Jones LW, Eves ND, Haykowsky M, Freedland SJ, Mackey JR (2009) Exercise intolerance in cancer and the role of exercise therapy to reverse dysfunction. Lancet Oncol 10:598–605
Courneya KS, Segal RJ, Mackey JR, Gelmon K, Reid RD, Friedenreich CM, Ladha AB, Proulx C, Vallance JKH, Lane K, Yasui Y, McKenzie DC (2007) Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial. J Clin Oncol 25:4396–4404
Kozachik SL, Bandeen-Roche K (2008) Predictors of patterns of pain, fatigue and insomnia during the first year following a cancer diagnosis in the elderly. Cancer Nurs 31:334
Rief W, Glombiewski JA, Barsky AJ (2009) Generic Assessment of Side Effects: GASE. www.GASE-scale.com
Lasheen W, Walsh D, Sarhill N, Davis M (2009) Intermittent cancer pain: clinical importance and an updated cancer pain classification. Am J Hosp Palliat Med 27(3):182–186
Rief W, Kaasa S, Jensen R, Perrot S, Vlaeyen JWS, Treede R-D, Vissers KCP (2010) The need to revise pain diagnoses in ICD-11. Pain 149:169–170
Paice JA (2011) Chronic treatment-related pain in cancer survivors. Pain 152:S84–S89
Kroenke K, Theobald D, Wu J, Norton K, Morrison G, Carpenter J, Tu W (2010) Effect of telecare management on pain and depression in patients with cancer. JAMA 304:163–171
Bishop SR, Warr D (2003) Coping, catastrophizing and chronic pain in breast cancer. J Behav Med 26:265–281
van den Beuken-van Everdingen MHJ, de Rijke JM, Kessels AG, Schouten HC, van Kleef M, Patijn J (2007) Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol 18:1437–1449
Deandrea S, Montanari M, Moja L, Apolone G (2008) Prevalence of undertreatment in cancer pain. A review of published literature. Ann Oncol 19:1985–1991
Acknowledgments
Winfried Rief receives research grants from the German Research Foundation DFG and the German Ministry of Education and Research BMBF for studies unrelated to the research discussed in this paper. Joel E. Dimsdale receives research grant support from Sepracor Pharmaceuticals and the NIH for studies unrelated to the research discussed in this paper. Loki Natarjan was supported on the NIH funded WHEL grant.
Conflicts of interest
No conflicts of interest to disclose.
Author information
Authors and Affiliations
Corresponding author
Additional information
This study is conducted for the Women’s Healthy Eating and Living (WHEL) Study Group.
Rights and permissions
About this article
Cite this article
Rief, W., Bardwell, W.A., Dimsdale, J.E. et al. Long-term course of pain in breast cancer survivors: a 4-year longitudinal study. Breast Cancer Res Treat 130, 579–586 (2011). https://doi.org/10.1007/s10549-011-1614-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-011-1614-z